C4 and Roche Expand DAC Cancer Drug Collaboration
WATERTOWN, Mass., April 09, 2026 C4 Therapeutics, Inc. has announced a major expansion of its long-term collaboration with Roche,...
Drug Discovery
Advertisement
Alloy and Biogen Partner on Antisense Drug Platform
BOSTON, Massachusetts, United States, April 7, 2026 Alloy Therapeutics Inc. announced a multi-target collaboration and license agreement with Biogen...
Regeneron Partners with TriNetX for 300M Patient Data
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced a strategic collaboration with TriNetX to...
Semarion Secures $3.8M to Advance Drug Discovery Tech
CAMBRIDGE, UK, March 31, 2026 Semarion, a University of Cambridge spin-out company, has announced the successful raise of $3.8...
Quotient Therapeutics, Merck Sign $2.2B IBD Deal
CAMBRIDGE, MASSACHUSETTS, March 24, 2026 Quotient Therapeutics has announced a multi-year research collaboration with Merck & Co. to discover...
Advertisements
Unnatural Products Secures $45M to Advance Peptides
SANTA CRUZ, Calif., March 16, 2026 Unnatural Products has announced the successful closing of a $45 million Series B...
Liquid AI, Insilico Launch AI Models for Drug Discovery
March 08, 2026 — Cambridge, MA, USA The rapid integration of artificial intelligence in pharmaceutical research continues to reshape...
Tenaya–Alnylam $1.13B Deal Targets Heart Disease Genes
South San Francisco, California — March 5, 2026 Tenaya Therapeutics and Alnylam Pharmaceuticals have announced a major research collaboration...
smartbax In-Licenses Novel Gram-Negative Antibiotic From Aicuris
MUNICH, Germany, January 20, 2026 — smartbax, a biotechnology company focused on next-generation antibiotics, announced the in-licensing of a...
Concept Life Sciences Appoints Adam Davenport as CSO
CHAPEL-EN-LE-FRITH, United Kingdom | January 19, 2026 — Concept Life Sciences, a leading global contract research organization (CRO) specializing...
Advertisement
